These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 29127345)

  • 1. The synthetic neuroactive steroid SGE-516 reduces seizure burden and improves survival in a Dravet syndrome mouse model.
    Hawkins NA; Lewis M; Hammond RS; Doherty JJ; Kearney JA
    Sci Rep; 2017 Nov; 7(1):15327. PubMed ID: 29127345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
    Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
    PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome.
    Anderson LL; Bahceci DA; Hawkins NA; Everett-Morgan D; Banister SD; Kearney JA; Arnold JC
    PLoS One; 2023; 18(1):e0280842. PubMed ID: 36701411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiating α
    Nomura T; Hawkins NA; Kearney JA; George AL; Contractor A
    J Physiol; 2019 Aug; 597(16):4293-4307. PubMed ID: 31045243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of stiripentol in hyperthermia-induced seizures in a mouse model of Dravet syndrome.
    Cao D; Ohtani H; Ogiwara I; Ohtani S; Takahashi Y; Yamakawa K; Inoue Y
    Epilepsia; 2012 Jul; 53(7):1140-5. PubMed ID: 22578034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endocannabinoid system impacts seizures in a mouse model of Dravet syndrome.
    Anderson LL; Doohan PT; Hawkins NA; Bahceci D; Garai S; Thakur GA; Kearney JA; Arnold JC
    Neuropharmacology; 2022 Mar; 205():108897. PubMed ID: 34822817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice.
    Hawkins NA; Jurado M; Thaxton TT; Duarte SE; Barse L; Tatsukawa T; Yamakawa K; Nishi T; Kondo S; Miyamoto M; Abrahams BS; During MJ; Kearney JA
    Epilepsia; 2021 Nov; 62(11):2845-2857. PubMed ID: 34510432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsant profile of the neuroactive steroid, SGE-516, in animal models.
    Hammond RS; Althaus AL; Ackley MA; Maciag C; Martinez Botella G; Salituro FG; Robichaud AJ; Doherty JJ
    Epilepsy Res; 2017 Aug; 134():16-25. PubMed ID: 28521115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an antiseizure drug screening platform for Dravet syndrome at the NINDS contract site for the Epilepsy Therapy Screening Program.
    Pernici CD; Mensah JA; Dahle EJ; Johnson KJ; Handy L; Buxton L; Smith MD; West PJ; Metcalf CS; Wilcox KS
    Epilepsia; 2021 Jul; 62(7):1665-1676. PubMed ID: 34002394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Na
    Richards KL; Milligan CJ; Richardson RJ; Jancovski N; Grunnet M; Jacobson LH; Undheim EAB; Mobli M; Chow CY; Herzig V; Csoti A; Panyi G; Reid CA; King GF; Petrou S
    Proc Natl Acad Sci U S A; 2018 Aug; 115(34):E8077-E8085. PubMed ID: 30076230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions.
    Anderson LL; Absalom NL; Abelev SV; Low IK; Doohan PT; Martin LJ; Chebib M; McGregor IS; Arnold JC
    Epilepsia; 2019 Nov; 60(11):2224-2234. PubMed ID: 31625159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synthetic neuroactive steroid SGE-516 reduces status epilepticus and neuronal cell death in a rat model of soman intoxication.
    Althaus AL; McCarren HS; Alqazzaz A; Jackson C; McDonough JH; Smith CD; Hoffman E; Hammond RS; Robichaud AJ; Doherty JJ
    Epilepsy Behav; 2017 Mar; 68():22-30. PubMed ID: 28109985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The European patient with Dravet syndrome: results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome.
    Aras LM; Isla J; Mingorance-Le Meur A
    Epilepsy Behav; 2015 Mar; 44():104-9. PubMed ID: 25666511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic signature of the Dravet syndrome in the genetic Scn1a-A1783V mouse model.
    Miljanovic N; Hauck SM; van Dijk RM; Di Liberto V; Rezaei A; Potschka H
    Neurobiol Dis; 2021 Sep; 157():105423. PubMed ID: 34144125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsant effect of equilibrative nucleoside transporters 1 inhibitor in a mouse model of Dravet syndrome.
    Ho SY; Chen IC; Tsai CW; Chang KC; Lin CJ; Chern Y; Liou HH
    Hippocampus; 2024 Jan; 34(1):7-13. PubMed ID: 37933097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic changes of depolarizing GABA in a computational model of epileptogenic brain: Insight for Dravet syndrome.
    Kurbatova P; Wendling F; Kaminska A; Rosati A; Nabbout R; Guerrini R; Dulac O; Pons G; Cornu C; Nony P; ; Chiron C; Benquet P
    Exp Neurol; 2016 Sep; 283(Pt A):57-72. PubMed ID: 27246997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling in a mouse model of Dravet syndrome.
    Hawkins NA; Calhoun JD; Huffman AM; Kearney JA
    Exp Neurol; 2019 Jan; 311():247-256. PubMed ID: 30347190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with dravet syndrome in the era of stiripentol: A French cohort cross-sectional study.
    De Liso P; Chemaly N; Laschet J; Barnerias C; Hully M; Leunen D; Desguerre I; Chiron C; Dulac O; Nabbout R
    Epilepsy Res; 2016 Sep; 125():42-6. PubMed ID: 27389706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donepezil increases resistance to induced seizures in a mouse model of Dravet syndrome.
    Wong JC; Thelin JT; Escayg A
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1566-1571. PubMed ID: 31402621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes.
    de Lange IM; Gunning B; Sonsma ACM; van Gemert L; van Kempen M; Verbeek NE; Nicolai J; Knoers NVAM; Koeleman BPC; Brilstra EH
    Epilepsia; 2018 Jun; 59(6):1154-1165. PubMed ID: 29750338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.